Should I have hip replacement surgery or wait?

From a triage perspective, this is a routine surgical-decision consultation, not an emergency — but routine does not mean unimportant. The decision has major life consequences and depends on data we do not yet have. Critical gaps include current pain severity at rest, with activity, and at night; weight-bearing imaging showing joint space, osteophytes, and any deformity; a documented history of structured physical therapy and what response it produced; and the patient's age, comorbidities, and the specific activities they are trying to preserve or regain.

Without those, the question of 'surgery now or wait' cannot be answered responsibly — only deferred. The next 1–2 weeks should be treated as a baseline-gathering window: validated outcome scoring, current radiographs, and an honest audit of the conservative care that has or has not happened. The surgical conversation belongs after that work, not before it.

From a movement standpoint, hip pathology produces a predictable cascade. Cartilage degradation narrows the joint space and disrupts normal arthrokinematics, and pain and effusion trigger arthrogenic muscle inhibition of the gluteus medius, gluteus maximus, and hip external rotators. The consequences move both proximally and distally — anterior pelvic tilt with lumbar hyperlordosis, contralateral pelvic drop in single-leg stance, knee valgus loading, and an antalgic gait pattern that raises the energy cost of walking by 30–40%. Many patients with significant hip pathology develop secondary low back pain because the spine is absorbing forces the hip can no longer manage.

A structured movement restoration program — capsular mobility work, glute med and max activation, hip flexor lengthening, and progression to step-ups, lateral band walks, and single-leg loading — addresses these compensations directly. The value of the program is the same on either path: it either reduces symptoms enough to delay or avoid surgery, or it sets up a substantially better post-operative recovery.

Functional rehabilitation is the lens that often clarifies the surgical question, because the answer to 'surgery or wait' frequently depends on what conservative work can actually achieve. Hip pathology produces a recognizable neuromuscular pattern — gluteus medius and maximus inhibition, external rotator shortening, sometimes quadriceps inhibition — and the resulting deconditioning amplifies perceived disability beyond what the structural damage alone would produce.

A well-structured 8–12 week program begins with neuromuscular re-education and progresses to functional loading: step-ups, partial squats, single-leg stance progressions, and hip-hinge patterning. Progress is judged against objective milestones — controlled single-leg squat without Trendelenburg drop, timed-up-and-go under 12 seconds, step-length symmetry within 10%, and pain with activities of daily living consistently at or below 3/10. If those milestones are reached, many patients have years of high-quality function ahead without surgery. If they cannot be reached after a genuine trial and imaging confirms significant structural compromise, the surgical conversation has the data it needs to be a confident one.

The psychological dimension of this decision is underappreciated but clinically meaningful. The framing of 'should I have surgery or wait' typically reflects decisional conflict — competing fears about acting and not acting, both legitimate, that can produce paralysis when left unaddressed. Research consistently shows that psychological readiness predicts surgical outcomes: patients who feel coerced, rushed, or unresolved going into hip replacement report lower satisfaction even when the operation is technically successful. Hesitation is not weakness so much as wisdom worth honoring.

At the same time, prolonged chronic pain has measurable psychological consequences — sensitization of pain pathways, depressive symptoms, fear-avoidance cycles — so indefinite indecision is not a safe alternative either. A structured decision-making process closes both gaps: gather information without commitment, clarify what matters most to you, consider a second opinion, complete a documented conservative trial if not already done, and make the decision with support rather than in isolation. The goal is to feel informed, not certain; certainty rarely arrives before action.

Literature search completed for elective hip replacement timing in symptomatic osteoarthritis. The critical finding is the absence of high-level direct evidence: no randomized controlled trials compare early versus delayed elective total hip arthroplasty for hip OA. The retrieved studies address adjacent questions — accelerated surgery for hip fracture (HIP ATTACK, Lancet 2020, showing that surgical delay in acute hip pathology carries measurable risk) and mechanical loading for bone preservation in older adults (Beavers et al., JAMA Network Open 2025, supporting pre-operative strengthening) — but the population mismatch from elective osteoarthritis surgery is significant.

Clinical decision-making for elective hip replacement therefore rests on observational registry data, cohort studies, and consensus guidelines from the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, which recommend surgery when conservative management has been optimized, imaging confirms significant joint space loss, and pain or functional limitation meaningfully impacts quality of life. GRADE certainty for the timing question is moderate at best; the decision is genuinely individual, and patient-specific factors carry most of the weight.